Zafgen to Present at Cowen 38th Annual Health Care Conference
March 07 2018 - 4:30PM
Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical
company leveraging its proprietary knowledge of MetAP2 systems
biology to develop novel therapies for patients affected by a range
of metabolic diseases, announced today that Jeffrey Hatfield,
Chief Executive Officer of Zafgen, Inc. will present a
company overview at the Cowen 38th Annual Health Care
Conference on Wednesday, March 14, 2018 at 10:00
a.m. ET.
A live audio webcast and replay of the presentation will be
available through the Events and Presentations page of the
Investors section of the Company's website (www.zafgen.com) for 90
days following the conclusion of the live event.
About Zafgen
Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical
company leveraging its proprietary knowledge of MetAP2 systems
biology to develop novel therapies for patients affected by a range
of complex metabolic diseases. Zafgen has pioneered the study of
MetAP2 inhibitors in both common and rare metabolic disorders, and
its current disease areas of focus are type 2 diabetes,
Prader-Willi syndrome and liver diseases. The company’s lead
product candidate is ZGN-1061, a MetAP2 inhibitor in Phase 2
clinical development with unique properties that maximize impact on
metabolic parameters relevant to the treatment of type 2 diabetes
and other related metabolic disorders. In 2018, Zafgen plans to
file an investigational new drug (IND) application with the U.S.
FDA and initiate Phase 1 clinical trials for ZGN-1258, its new
molecule for the treatment of Prader-Willi syndrome and potential
other rare and serious forms of obesity. Learn more at
www.zafgen.com.
Media/Investor Relations Contacts:Zafgen,
Inc.Patricia AllenChief Financial Officer617-648-9792
MediaKrystle GibbsTen Bridge Communications
krystle@tenbridgecommunications.com 508-479-6358
InvestorsJohn WoolfordWestwicke
PartnersJohn.woolford@westwicke.com 443-213-0506
Zafgen (NASDAQ:ZFGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Zafgen (NASDAQ:ZFGN)
Historical Stock Chart
From Apr 2023 to Apr 2024